Preclinical & Clinical Immunophenotyping Innovation in Acute Myeloid Leukemia

Presented by

Brandon L. Walling, PhD - Associate Director Flow Cytometry at Champions Oncology

About this talk

Determining an effective treatment for AML has been challenging due to the heterogeneity of the disease and the diverse subpopulations that drive the disease in each patient. Also, a better understanding of the role of the immune system in AML has created new interest in developing effective therapies for the treatment of patients. Flow Cytometry is used not only for clinical diagnosis of the disease but also for interrogation of the diverse subpopulations that exist within AML to explore more treatments that could lead to a cure. Attend this webinar to learn: • Important considerations when designing cytometry-based assays for hematological malignancy indications. • The design and development of cytometry-based assays for preclinical and clinical applications. • Validation of a high complexity 18-color panel to interrogate AML patient samples.
Related topics:

More from this channel

Upcoming talks (4)
On-demand talks (61)
Subscribers (3397)
Champions Oncology delivers innovative solutions to oncology drug development, accelerating the journey from the research bench to the clinic – decreasing timelines, lowering costs, and ultimately saving patient lives. Learn more about Champions Oncology's capabilities, our service platforms and educational topics affecting our industry on our Webinar Channel.